DNA technology

Committee on DNA Technology in Forensic Science ReportF 2L ion.S. Research Council, Committee on DNA Technology in Forensic Science, National Academy Press, Washington, D.C., 1992. 

Methionyl hGH. The first form of hGH to be produced through recombinant DNA technology was actually a derivative of hGH having one additional methionine residue at its N-terminus (11). Although technology has advanced to the stage where natural sequence hGH can easily be produced, as of this writing this derivative, referred to as methionyl hGH, is stiU produced commercially. 

Point Mutations. Since the advent of recombinant DNA technology, a number of researchers have used point mutation techniques either to delete one or more residues within the hGH molecule or systematically to change from one amino acid to another to probe hGH stmcture/function relationships (33). 

Human growth hormone was originally manufactured by isolation of the natural product from human pituitaries and subsequent purification of the protein. Since 1985, manufacture of hGH has been almost exclusively by recombinant DNA technology. 

Human growth hormone is one of the largest selling therapeutic proteins produced by recombinant DNA technology. Annual worldwide sales increased from 130,000,000 in 1987 to 575,000,000 in 1992 (47). Upon approval of additional indications, the sales of hGH are expected to increase even more. 

Recombinant DNA technology has already provided several products of therapeutic interest from mammalian cells. Table 2 gives examples of products from mammalian cells, the use, and the technology used for production. Technology development for these products has centered around the differences in characteristics of mammalian versus microbial cells, notably, the shear sensitivity and susceptibiUty to contamination of the mammalian lines. 

Superoxide dismutase has been approved by the FDA for preventing reperfusion injury or damage to donor organ tissue (178). This enzyme is prepared by recombinant DNA technology and marketed by Bristol-Myers and Pharmacia-Chiron. 

Microbes for Industiial and Agiicultural Applications, Dekker, NY, 1993. Click, B. R. and J. J. Pasternak, Molecular Biotechnology Trinciples and Applications of Recombinant DNA, ASM Press, Herndon, VA, 1994. Bajpai, Rakesb K., and Ales Prokop, eds. Recombinant DNA Technology II, Annals of the New York Academy of Sciences, vol. 721, 1993. 

Polymerase Chain Reacdon (PCR) Recombinant DNA Technology An Excidng Sciendfic Frontier... 

Recombinant DNA technology now verges on the ability to engineer at will the genetic constitution of organisms for desired ends. The commercial production of therapeutic biomolecules in microbial cultures is already established (for example, the production of human insulin in quantity in E. coli cells). Agricultural crops with desired attributes, such as enhanced resistance to her-... 

---